Granted Patent
B2
US 7,390,823 · App. 10/409,504 · Granted Jun 24, 2008
Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders
Assignee:
Sanofi-Aventis
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to the use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders.
Claims (1)
1. A method for the treatment of major depressive disorders which comprises administering to a patient in need of such treatment an effective amount of saredutant or a pharmaceutically acceptable salt thereof.
Assignments (2)
CHANGE OF NAME
Recorded Jul 22, 2005
From: SANOFI-SYNTHELABO
To: SANOFI-AVENTIS
Reel/Frame 016345/0189 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 16, 2005
From: EMONDS-ALT, XAVIER; SOUBRIE, PHILIPPE; STEINBERG, REGIS
To: SANOFI-SYNTHELABO
Reel/Frame 015896/0914 →
Priority Claims (1)
FR 99 05338
· Apr 27, 1999
· national
Continuity (2)
Continuation
0995843900